High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity
- 10 May 2004
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 34 (1), 69-76
- https://doi.org/10.1038/sj.bmt.1704529
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myelomaBritish Journal of Haematology, 2002
- Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantationBlood, 2001
- Randomized trial experience of the Intergroupe Francophone du MyélomeSeminars in Hematology, 2001
- Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cellsCurrent Opinion in Hematology, 2000
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical TrialBlood, 1998
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collectionsBritish Journal of Haematology, 1996
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patientsThe Lancet, 1996